Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study

✍ Scribed by Bjorn Gudbjornsson; Sigurdur B. Thorsteinsson; Helgi Sigvaldason; Rannveig Einarsdottir; Magnus Johannsson; Helga Zoega; Matthias Halldorsson; Gudmundur Thorgeirsson

• Book ID: 105922006
• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 134 KB
• Volume: 66
• Category: Article
• ISSN: 0031-6970
• DOI: 10.1007/s00228-010-0789-2